A Study of Maintenance Treatment With Fluzoparib in gBRCA/PALB2 Mutated Pancreatic Cancer Whose Disease Has Not Progressed on First Line Platinum-Based Chemotherapy
Jiangsu HengRui Medicine Co., Ltd.
Jiangsu HengRui Medicine Co., Ltd.
Albert Einstein College of Medicine
Medical University of Graz
Gilead Sciences
Lumos Pharma
University of Zurich
Assistance Publique - HĂ´pitaux de Paris
Incyte Corporation
Universitätsklinikum Hamburg-Eppendorf
Incyte Corporation
Par Pharmaceutical, Inc.
Sanofi
Sanofi
University of Rochester
CHIR-Net
National Center for Tumor Diseases, Heidelberg
GERCOR - Multidisciplinary Oncology Cooperative Group
Massachusetts General Hospital
Pfizer
Pharmexa A/S